A Randomized, Double-Blind, Placebo-Controlled, Study Investigating Vaccine Responses in Adults With Moderate to Severe Atopic Dermatitis Treated With Dupilumab
Phase of Trial: Phase II
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Regeneron Pharmaceuticals
- 29 Sep 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 22 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 24 Sep 2014 Trial status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.